Stay updated with breaking news from Study Design. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
VBI Vaccines Inc. , a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that new interim tumor response data from the...
VBI Vaccines Inc. announced that new interim tumor response data from the ongoing randomized, controlled Phase 2b study of VBI-1901, the Company's cancer vaccine immunotherapeutic candidate in...
As consumer interest in natural extracts grows, a clinical study highlights the effectiveness of an allergen-free herbal treatment for acne vulgaris.
Results of a Phase 1, Open-label,Dose-escalation Study of Gene Therapy with AAV2-hAQP1 as Treatment for Grade 2 and 3 Radiation-induced Late Xerostomia and Parotid Gland Hypofunction -...
Comparison of prostate cancer mortality rate conducted on subjects with a single invitation for PSA screening.